Cite
MLA Citation
S. Isakoff et al.. “A phase 1 study of MM-141, a novel tetravalent monoclonal antibody targeting IGF-1R and ErbB3, in relapsed or refractory solid tumors.” European journal of cancer, vol. 69, n.d., pp. S137–S138. http://access.bl.uk/ark:/81055/vdc_100039473461.0x00004f